119 related articles for article (PubMed ID: 12823747)
41. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
42. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy.
Humpe A; Riggert J; Vehmeyer K; Troff C; Hiddemann W; Köhler M; Wörmann B
Transfusion; 1997 Oct; 37(10):1050-7. PubMed ID: 9354824
[TBL] [Abstract][Full Text] [Related]
43. Thawed autologous peripheral blood stem cells require modified quantification methods for hematopoietic progenitor cell evaluation.
Decot V; Alla F; Latger-Cannard V; Visanica S; Witz B; Stoltz JF; Bensoussan D
Biomed Mater Eng; 2012; 22(1-3):57-67. PubMed ID: 22766703
[TBL] [Abstract][Full Text] [Related]
44. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
Bolwell BJ; Goormastic M; Andresen S; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
[TBL] [Abstract][Full Text] [Related]
45. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
46. The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.
Collins NH; Gee AP; Durett AG; Kan F; Zhang MJ; Champlin RE; Confer D; Eapen M; Howard A; King R; Laughlin MJ; Plante RJ; Setterholm M; Spellman S; Keever-Taylor C; Wagner JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2010 Feb; 16(2):253-62. PubMed ID: 19822219
[TBL] [Abstract][Full Text] [Related]
47. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED
Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
[TBL] [Abstract][Full Text] [Related]
48. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
[TBL] [Abstract][Full Text] [Related]
49. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
50. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
Bolwell B; Goormastic M; Andresen S; Koo A; Wise K; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1998 Sep; 22(6):547-51. PubMed ID: 9758341
[TBL] [Abstract][Full Text] [Related]
51. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.
Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE
Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729
[TBL] [Abstract][Full Text] [Related]
52. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?
Fietz T; Reufi B; Mücke C; Thiel E; Knauf WU
J Hematother Stem Cell Res; 2002 Apr; 11(2):429-35. PubMed ID: 11983115
[TBL] [Abstract][Full Text] [Related]
54. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.
Specchia G; Pastore D; Mestice A; Liso A; Carluccio P; Leo M; Casanova M; Sibilla S; Giannoccaro M; Liso V
Acta Haematol; 2006; 116(4):229-37. PubMed ID: 17119322
[TBL] [Abstract][Full Text] [Related]
55. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
56. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
Mayer J; Korístek Z; Pospísil Z; Vásová I; Adam Z; Hájek R; Krejcí M; Král Z; Navrátil M; Vorlícek J; Bourková L; Matýsková M; Adler J; Vinklárková J; Klabusay M; Koutná I; Hoffová V; Schmitzová D; Janovská E
Cas Lek Cesk; 1999 Mar; 138(6):170-7. PubMed ID: 10510531
[TBL] [Abstract][Full Text] [Related]
57. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
[TBL] [Abstract][Full Text] [Related]
58. Possibility of progenitor cell mobilization during the hematological recovery following peripheral blood stem cell autograft.
De Propris MS; Meloni G; Cordone I; Capria S; Bellucci R; Trisolini S; Simone F; de Fabritiis P
Acta Haematol; 2003; 109(2):57-63. PubMed ID: 12624488
[TBL] [Abstract][Full Text] [Related]
59. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
60. Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation.
Begemann PG; Hassan HT; Kröger N; Krüger W; Kabisch H; Zander AR
J Hematother Stem Cell Res; 2002 Apr; 11(2):321-6. PubMed ID: 11983103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
